| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |